Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
17009 2014 First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
New England Journal of Medicine 371 (23), 2167-2177, 2014
3661 2014 Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a … H Wilke, K Muro, E Van Cutsem, SC Oh, G Bodoky, Y Shimada, ...
The lancet oncology 15 (11), 1224-1235, 2014
2544 2014 Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer S Peters, DR Camidge, AT Shaw, S Gadgeel, JS Ahn, DW Kim, SHI Ou, ...
New England Journal of Medicine 377 (9), 829-838, 2017
2411 2017 Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma J Weber, M Mandala, M Del Vecchio, HJ Gogas, AM Arance, CL Cowey, ...
New England Journal of Medicine 377 (19), 1824-1835, 2017
2310 2017 Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim, B Bui-Nguyen, ...
The Lancet 379 (9829), 1879-1886, 2012
2264 2012 Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin’s lymphoma JM Connors, W Jurczak, DJ Straus, SM Ansell, WS Kim, A Gallamini, ...
New England Journal of Medicine 378 (4), 331-344, 2018
771 2018 Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ...
The Lancet Oncology 19 (4), 521-536, 2018
560 2018 Effect of supplementation of Bacillus subtilis LS 1-2 to broiler diets on growth performance, nutrient retention, caecal microbiology and small intestinal morphology S Sen, SL Ingale, YW Kim, JS Kim, KH Kim, JD Lohakare, EK Kim, HS Kim, ...
Research in Veterinary Science 93 (1), 264-268, 2012
332 2012 Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the … B Keam, SA Im, HJ Kim, DY Oh, JH Kim, SH Lee, EK Chie, W Han, ...
BMC cancer 7, 1-11, 2007
253 2007 Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK -Positive Non–Small-Cell Lung Cancer SM Gadgeel, AT Shaw, R Govindan, L Gandhi, MA Socinski, DR Camidge, ...
Journal of Clinical Oncology 34 (34), 4079-4085, 2016
203 2016 Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group TM Kim, SY Lee, YK Jeon, BY Ryoo, GJ Cho, YS Hong, HJ Kim, SY Kim, ...
Annals of Oncology 19 (8), 1477-1484, 2008
184 2008 Search for the direct production of charginos and neutralinos in final states with tau leptons in pp collisions with the ATLAS detector M Aaboud, G Aad, B Abbott, O Abdinov, B Abeloos, SH Abidi, ...
The European Physical Journal C 78, 1-33, 2018
171 * 2018 Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ...
Annals of Oncology 27 (3), 417-423, 2016
162 2016 Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis HS Kim, HJ Kim, SY Kim, TY Kim, KW Lee, SK Baek, MH Ryu, BH Nam, ...
Annals of Oncology 24 (11), 2850-2854, 2013
156 2013 Harpoon: a flow-level traffic generator for router and network tests J Sommers, H Kim, P Barford
ACM SIGMETRICS Performance Evaluation Review 32 (1), 392-392, 2004
155 2004 Exposure to volatile organic compounds and loss of pulmonary function in the elderly HI Yoon, YC Hong, SH Cho, H Kim, YH Kim, JR Sohn, M Kwon, SH Park, ...
European respiratory journal 36 (6), 1270-1276, 2010
136 2010 Characterization of large structural genetic mosaicism in human autosomes MJ Machiela, W Zhou, JN Sampson, MC Dean, KB Jacobs, A Black, ...
The American Journal of Human Genetics 96 (3), 487-497, 2015
133 2015 Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in β-amyloid-treated C6 glioma cells Y Kim, SY Lim, SH Rhee, KY Park, CH Kim, BT Choi, SJ Lee, YM Park, ...
International journal of molecular medicine 17 (6), 1069-1075, 2006
126 2006 INDUCTWISE: Inductance-wise interconnect simulator and extractor TH Chen, C Luk, H Kim, CCP Chen
Proceedings of the 2002 IEEE/ACM international conference on Computer-aided …, 2002
120 2002